TSW
DMTK

Thompson Siegel & Walmsley’s DermTech, Inc. Common Stock DMTK Stock Holding History

Thompson Siegel & Walmsley’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,462
Closed -$80K – 796
2020
Q4 		$80K Buy
+2,462
New +$34.9K ﹤0.01% 407

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Thompson Siegel & Walmsley's DMTK Position: Q1 2021 in Review

Thompson Siegel & Walmsley sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2021, closing a stake of 2,462 shares — an estimated $80K sold.

Thompson Siegel & Walmsley first reported a position in DMTK in Q4 2020 and held it in 1 quarter. The position peaked at $80K in Q4 2020. 169 funds tracked by Wall St. Rank hold DMTK as of Q1 2021.

  • Thompson Siegel & Walmsley reported no remaining DermTech, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 2,462 DermTech, Inc. Common Stock shares in Q1 2021, an estimated $80K.
  • Thompson Siegel & Walmsley first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Thompson Siegel & Walmsley's DermTech, Inc. Common Stock position peaked at $80K in Q4 2020.
  • 169 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2021.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2021, filed 7 May 2021.